| Trial ID: | L5643 |
| Source ID: | NCT00562952
|
| Associated Drug: |
Telmisartan, Bisoprolol
|
| Title: |
Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
|
| Acronym: |
PONTIAC
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Heart Failure|Coronary Artery Disease
|
| Interventions: |
DRUG: Telmisartan, Bisoprolol|DRUG: placebo
|
| Outcome Measures: |
Primary: Reduction in cardiac events, 2 | Secondary: Decrease in NT-pro-BNP in the treatment arm, 1|Reduction in NT-proBNP, 1
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna | Collaborators: Roche Pharma AG
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2007-11
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-05-03
|
| Locations: |
General Hospital of Vienna Department of Endocrinology, Vienna, 1090, Austria|Medical University of Vienna, Vienna, 1090, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT00562952
|
